 | Up a level |
Hart, X M; Gründer, G; Ansermot, N; Conca, A; Corruble, E; Crettol, S; Cumming, P; Hefner, G; Frajerman, A; Howes, O; Jukic, M; Kim, E; Kim, S; Manisalco, I; Moriguchi, S; Müller, D J; Nakajima, S; Osugo, M; Paulzen, M; Ruhe, H G; ... (2024). Optimisation of pharmacotherapy in psychiatry through therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests: focus on antipsychotics. (In Press). The world journal of biological psychiatry, pp. 1-123. Taylor & Francis 10.1080/15622975.2024.2366235
Quteineh, L; Bochud, P-Y; Golshayan, D; Crettol, S; Venetz, J-P; Manuel, O; Kutalik, Z; Treyer, A; Lehmann, R; Mueller, N J; Binet, I; van Delden, C; Steiger, J; Mohacsi, P; Dufour, Jean-François; Soccal, P M; Pascual, M; Semmo, Nasser; Beldi, Guido and Eap, C B (2015). CRTC2 polymorphism as a risk factor for the incidence of metabolic syndrome in patients with solid organ transplantation. Pharmacogenomics journal, 17(1), pp. 69-75. Nature Publishing Group 10.1038/tpj.2015.82
Oneda, B; Crettol, S; Bochud, M; Besson, J; Croquette-Krokar, M; Hämmig, R; Monnat, M; Preisig, M; Eap, C B (2011). β-Arrestin2 influences the response to methadone in opioid-dependent patients. Pharmacogenomics journal, 11(4), pp. 258-66. Basingstoke: Nature Publishing Group 10.1038/tpj.2010.37
